Sorensen Mel 4
4 · Galera Therapeutics, Inc. · Filed Feb 4, 2020
Insider Transaction Report
Form 4
Sorensen Mel
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2020-01-31+186,087→ 186,087 totalExercise: $14.84Exp: 2030-01-30→ Common Stock (186,087 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in equal monthly installments over a four year period commencing January 31, 2020.